Institution
Basque Government
Government•Vitoria-Gasteiz, Spain•
About: Basque Government is a government organization based out in Vitoria-Gasteiz, Spain. It is known for research contribution in the topics: Population & European Prospective Investigation into Cancer and Nutrition. The organization has 252 authors who have published 458 publications receiving 18487 citations. The organization is also known as: Eusko Jaurlaritza.
Topics: Population, European Prospective Investigation into Cancer and Nutrition, Prospective cohort study, Pregnancy, Cancer
Papers published on a yearly basis
Papers
More filters
Utrecht University1, University of Copenhagen2, University of Düsseldorf3, University of Ulm4, National and Kapodistrian University of Athens5, Imperial College London6, University College London7, Umeå University8, National Institutes of Health9, Norwegian Institute of Public Health10, University of Oslo11, Karolinska Institutet12, Aarhus University13, University Medical Center Utrecht14, Cancer Epidemiology Unit15, Swiss Tropical and Public Health Institute16, University of Basel17, French Institute of Health and Medical Research18, Institut Gustave Roussy19, University of Washington20, University of Turin21, Basque Government22
TL;DR: In this article, the authors investigated the association between natural-cause mortality and long-term exposure to several air pollutants, such as PM2.5, nitrogen oxides, and NOx.
1,056 citations
University of Cambridge1, Australian National University2, Norwegian Institute of Public Health3, Utrecht University4, University of Tromsø5, University of Oxford6, The George Institute for Global Health7, Johns Hopkins University8, National Institutes of Health9, University of Copenhagen10, Copenhagen University Hospital11, University of Western Australia12, Fiona Stanley Hospital13, Harry Perkins Institute of Medical Research14, University of London15, Lund University16, University of Pittsburgh17, French Institute of Health and Medical Research18, University College London19, Technische Universität München20, University of Ulm21, University of Padua22, University of Southampton23, German Cancer Research Center24, Erasmus University Medical Center25, Umeå University26, Cardiff University27, Greifswald University Hospital28, Aarhus University29, Portland State University30, University of New South Wales31, National and Kapodistrian University of Athens32, Harvard University33, University of Hawaii34, Columbia University35, University of Iowa36, Duke University37, Yamagata University38, Tuskegee University39, University of Helsinki40, University of Oulu41, Medical University of South Carolina42, University of Washington43, Kaiser Permanente44, University of Groningen45, University of Granada46, Yale University47, Prevention Institute48, University of Edinburgh49, Uppsala University50, Basque Government51, Kyushu University52, Royal Prince Alfred Hospital53, Harokopio University54, University of California, San Diego55, VU University Medical Center56, Aalborg University57, University of Eastern Finland58, Laval University59, University of Vermont60, Wake Forest University61, Wake Forest Baptist Medical Center62, Kanazawa Medical University63, Baker IDI Heart and Diabetes Institute64, Heidelberg University65, Istituto Superiore di Sanità66, Pasteur Institute67, City College of New York68, Howard University69, University of Glasgow70, International Agency for Research on Cancer71, University of Bristol72, University of Auckland73
TL;DR: Current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week, and data support limits for alcohol consumption that are lower than those recommended in most current guidelines.
711 citations
University of Cambridge1, MRC Human Nutrition Research2, University of Oxford3, Utrecht University4, Wageningen University and Research Centre5, Basque Government6, Institut Gustave Roussy7, French Institute of Health and Medical Research8, Lund University9, Umeå University10, Aarhus University11, University of Naples Federico II12, Aalborg University13, Prevention Institute14, University of Turin15, University of Granada16, Andalusian School of Public Health17, International Agency for Research on Cancer18, University of Murcia19, Imperial College London20
TL;DR: Different individual plasma phospholipid SFAs were associated with incident type 2 diabetes in opposite directions, which suggests that SFAs are not homogeneous in their effects.
457 citations
David M.S. McHugh1, Cynthia A. Cameron, Jose E. Abdenur2, Mahera Abdulrahman +242 more•Institutions (75)
TL;DR: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders.
303 citations
National Institutes of Health1, International Agency for Research on Cancer2, German Cancer Research Center3, Basque Government4, University of Oxford5, University of Cambridge6, National and Kapodistrian University of Athens7, Harvard University8, Academy of Athens9, Utrecht University10, University of Naples Federico II11, Imperial College London12, Umeå University13, Lund University14
TL;DR: The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis.
Abstract: Purpose Human papillomavirus type 16 (HPV16) infection is causing an increasing number of oropharyngeal cancers in the United States and Europe. The aim of our study was to investigate whether HPV antibodies are associated with head and neck cancer risk when measured in prediagnostic sera. Methods We identified 638 participants with incident head and neck cancers (patients; 180 oral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers) and 300 patients with esophageal cancers as well as 1,599 comparable controls from within the European Prospective Investigation Into Cancer and Nutrition cohort. Prediagnostic plasma samples from patients (collected, on average, 6 years before diagnosis) and control participants were analyzed for antibodies against multiple proteins of HPV16 as well as HPV6, HPV11, HPV18, HPV31, HPV33, HPV45, and HPV52. Odds ratios (ORs) of cancer and 95% CIs were calculated, adjusting for potential confounders. All-cause mortality was evaluated among patients using Cox proportional hazards regression. Results HPV16 E6 seropositivity was present in prediagnostic samples for 34.8% of patients with oropharyngeal cancer and 0.6% of controls (OR, 274; 95% CI, 110 to 681) but was not associated with other cancer sites. The increased risk of oropharyngeal cancer among HPV16 E6 seropositive participants was independent of time between blood collection and diagnosis and was observed more than 10 years before diagnosis. The all-cause mortality ratio among patients with oropharyngeal cancer was 0.30 (95% CI, 0.13 to 0.67), for patients who were HPV16 E6 seropositive compared with seronegative.
299 citations
Authors
Showing all 252 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Miren Dorronsoro | 75 | 259 | 20774 |
| Pilar Amiano | 70 | 328 | 16989 |
| Nerea Larrañaga | 61 | 176 | 12011 |
| Larraitz Arriola | 51 | 105 | 7658 |
| Jesús Ibarluzea | 40 | 136 | 6907 |
| Carmen Pérez-Rodrigo | 37 | 84 | 5406 |
| Pablo Martínez-Camblor | 34 | 204 | 5101 |
| Pilar Amiano | 33 | 43 | 3617 |
| Javier Aranceta | 32 | 55 | 4389 |
| David Carmena | 29 | 93 | 3377 |
| Aitana Lertxundi | 28 | 79 | 2387 |
| Andreia Oliveira | 27 | 116 | 2036 |
| Loreto Santa-Marina | 22 | 61 | 1574 |
| Santiago Esnaola | 22 | 51 | 2976 |
| Jone M. Altzibar | 21 | 39 | 1586 |